Abstract library

4 results for "Biran".
#372 A Retrospective Analysis of Neuroendocrine Tumors (NETs) in West Azarbaijan of Iran
Introduction: NETs are most often located in the intestine and lungs but they can occur in other areas of the body. Limited data are available on epidemiology and clinical patterns of NETs in Iran.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr Nasim Valizadeh
#1382 Appropriate Indication of Organ Preserving Surgery for Pancreatic Neuroendocrine Neoplasm
Introduction: Organ preserving surgery(OPS) has been accepted for pancreatic neuroendocrine neoplasm(PNEN), particularly in a small and low malignant tumors.
Conference: 13th Annual ENETS conference (2016)
Category: Surgical treatment
Presenting Author: Dr Takahiro Tsuchikawa
#1812 Correlation of Plasma (p) and Urine (u) 5-HIAA Levels in Patients (pts) with Carcinoid Syndrome (CS) – Post-Hoc Analyses from the TELESTAR Study
Introduction: Telotristat ethyl (TE) is an oral tryptophan hydroxylase inhibitor in development for treating CS symptoms. During the double-blind treatment [DBT] period of the phase 3, 12-week, placebo-controlled TELESTAR study, TE was well tolerated and significantly reduced bowel-movement frequency and u5-HIAA levels compared with placebo (PBO) in NET patients with CS treated with a SSA.
Conference: 14th Annual ENETS conference (2017)
Category: Medical treatment - Others
Presenting Author: Marianne Pavel
#1941 Integrated Safety Analysis of Telotristat Ethyl in Patients with Carcinoid Heart Disease
Introduction: Release of serotonin by neuroendocrine tumors is associated with carcinoid heart disease (CaHD), which may pose challenges for carcinoid syndrome (CS) treatment.
Conference: 14th Annual ENETS conference (2017)
Category: Medical treatment - Targeted therapies
Presenting Author: Dr Pablo Lapuerta
Authors: Lapuerta P, Kulke M H, Pavel M, Biran T, ...
Keywords: serotonin, 5-HIAA